Position in ABBV
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$5,048,904
+$695,625 QoQ
Shares Held
20,064
+0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.34%
of 13F equity value
Holder Rank
#1,304
of 4,153 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Keudell/Morrison Wealth Management holds $22,085,611 across 13 Drug Manufacturers - General names. ABBV ranks #2 (22.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,989 | $5,983,956 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
20,064 | $5,048,904 | |
| 3 | JNJ |
Johnson & Johnson
|
7,437 | $1,888,774 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
14,835 | $1,874,253 | |
| 5 | AMGN |
Amgen Inc
|
4,952 | $1,793,218 | |
| 6 | MRK |
Merck & Co., Inc.
|
13,268 | $1,704,938 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
19,945 | $1,149,230 | |
| 8 | SNY |
Sanofi
|
14,344 | $611,915 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,048,904 | 20,064 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $4,353,279 | 20,016 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $4,561,345 | 19,963 | Shares | Sole | 2026-02-06 | |
| 2025-06-30 | $3,974,495 | 21,412 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $4,604,621 | 21,977 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $3,879,901 | 21,834 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $4,247,597 | 21,509 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $3,825,239 | 22,302 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $4,109,632 | 22,568 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $3,710,601 | 23,944 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,648,094 | 24,474 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $3,367,980 | 24,998 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $4,124,654 | 25,881 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $4,243,393 | 26,257 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $3,575,622 | 26,642 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $4,135,932 | 27,004 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $4,728,586 | 29,169 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $4,055,636 | 29,953 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $3,313,442 | 30,717 | Shares | Sole | 2021-12-08 | |
| 2021-06-30 | $3,294,494 | 29,248 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $3,128,640 | 28,910 | Shares | Sole | 2021-04-13 | |
| 2020-12-31 | $2,893,585 | 27,005 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,400,316 | 27,404 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $2,742,658 | 27,935 | Shares | Sole | 2020-07-14 | |
| 2020-03-31 | $2,041,206 | 26,791 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||